Japan Finally Approves Mifepristone To Public Support

Use, Monitoring Requirements

Japan has approved abortion drug mifepristone but will limit its use to clinics with authorized physicians, with strict nationwide monitoring of sales. The majority of more than 10,000 public comments around the approval were in support of the new option for women. 

Mifepristone was approved in Japan on 28 April, 2023
Japan demand for mifespristone had been rising as a new option for abortion • Source: Shutterstock

More from Japan

More from Asia